Virginie Nerich

1.7k total citations
83 papers, 1.2k citations indexed

About

Virginie Nerich is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Virginie Nerich has authored 83 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 24 papers in Economics and Econometrics and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Virginie Nerich's work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Economic and Financial Impacts of Cancer (11 papers) and Pharmaceutical Practices and Patient Outcomes (10 papers). Virginie Nerich is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (20 papers), Economic and Financial Impacts of Cancer (11 papers) and Pharmaceutical Practices and Patient Outcomes (10 papers). Virginie Nerich collaborates with scholars based in France, Austria and Australia. Virginie Nerich's co-authors include Samuel Limat, Xavier Pivot, Bernhard Holzner, Eva‐Maria Gamper, Élisabeth Monnet, Alain Weill, Georg Kemmler, Stéphane Rican, H. Allemand and Franck Carbonnel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Virginie Nerich

80 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Virginie Nerich France	20	334	221	208	199	194	83	1.2k
Gregory S. Calip United States	24	632 1.9×	273 1.2×	202 1.0×	133 0.7×	204 1.1×	175	2.1k
Amy Cantor United States	24	648 1.9×	271 1.2×	128 0.6×	215 1.1×	214 1.1×	57	2.2k
Mark Liebow United States	23	229 0.7×	172 0.8×	216 1.0×	150 0.8×	146 0.8×	44	1.5k
Mark J. Rutherford United Kingdom	23	726 2.2×	299 1.4×	258 1.2×	101 0.5×	384 2.0×	90	2.0k
Anai N. Kothari United States	20	370 1.1×	128 0.6×	129 0.6×	48 0.2×	203 1.0×	100	1.4k
Chris Skedgel Canada	21	198 0.6×	101 0.5×	319 1.5×	90 0.5×	85 0.4×	76	1.3k
Louise Emilsson Sweden	22	419 1.3×	389 1.8×	123 0.6×	199 1.0×	238 1.2×	65	1.6k
Ji Young Lee United States	19	410 1.2×	142 0.6×	88 0.4×	45 0.2×	260 1.3×	68	1.3k
George Dranitsaris Canada	28	774 2.3×	148 0.7×	449 2.2×	140 0.7×	247 1.3×	105	2.3k
Shazia Mehmood Siddique United States	16	377 1.1×	345 1.6×	83 0.4×	417 2.1×	194 1.0×	60	1.6k

Countries citing papers authored by Virginie Nerich

Since Specialization

Citations

This map shows the geographic impact of Virginie Nerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Nerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Nerich more than expected).

Fields of papers citing papers by Virginie Nerich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Nerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Nerich. The network helps show where Virginie Nerich may publish in the future.

Co-authorship network of co-authors of Virginie Nerich

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Nerich. A scholar is included among the top collaborators of Virginie Nerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Nerich. Virginie Nerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laroche, Marie‐Laure, et al.. (2024). Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT‐ECO study. British Journal of Clinical Pharmacology. 91(2). 439–450. 2 indexed citations

Nerich, Virginie, et al.. (2023). Pre-operative and early postoperative health-related quality of life of breast cancer woman: a Lebanese prospective study. BMC Women s Health. 23(1). 187–187. 3 indexed citations

Slekovec, C., Quentin Lepiller, Agnès Guillaume, et al.. (2023). French healthcare students and antibiotics: are they ready to promote their appropriate use?. JAC-Antimicrobial Resistance. 6(1). dlad147–dlad147. 2 indexed citations

Thiery-Vuillemin, Antoine, et al.. (2022). Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review of Economic Evaluations. Clinical Genitourinary Cancer. 20(6). 594–602. 4 indexed citations

Anota, Amélie, Tienhan Sandrine Dabakuyo‐Yonli, Françis Guillemin, et al.. (2022). Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments. Quality of Life Research. 31(10). 3077–3085. 2 indexed citations

Oudard, Stéphane, Gwénaëlle Gravis, F. Kleinclauss, et al.. (2021). Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer. Clinical Genitourinary Cancer. 19(5). e326–e333. 11 indexed citations

Kapel, Nathalie, Frédéric Grenouillet, Stéphane Koch, et al.. (2020). A systematic review of economic evaluation in fecal microbiota transplantation. Infection Control and Hospital Epidemiology. 41(4). 458–466. 8 indexed citations

Curtit, Elsa, et al.. (2019). Interaction between phytotherapy and oral anticancer agents: prospective study and literature review. Medical Oncology. 36(5). 45–45. 49 indexed citations

Gamper, Eva‐Maria, Bernhard Holzner, Madeleine King, et al.. (2018). Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health States. Value in Health. 21(8). 958–966. 30 indexed citations

10.

Gamper, Eva‐Maria, Virginie Nerich, Monika Sztankay, et al.. (2017). Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical Routine. Value in Health. 20(4). 610–617. 10 indexed citations

11.

Fagnoni, Philippe, Angélique Vienot, Christophe Borg, et al.. (2017). A systematic review of economic evaluation in pancreatic ductal adenocarcinoma. European Journal of Cancer. 86. 207–216. 12 indexed citations

12.

Nerich, Virginie, Eva‐Maria Gamper, Bernhard Holzner, et al.. (2017). Critical appraisal of health-state utility values used in breast cancer-related cost–utility analyses. Breast Cancer Research and Treatment. 164(3). 527–536. 10 indexed citations

13.

Nerich, Virginie, et al.. (2016). Cost–utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment. 159(3). 407–424. 15 indexed citations

14.

Jary, Marine, François Ghiringhelli, Marion Jacquin, et al.. (2014). Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer Chemotherapy and Pharmacology. 74(1). 141–150. 6 indexed citations

15.

Nerich, Virginie, Elsa Curtit, Fernando Bazán, et al.. (2014). Évaluation économique de l’utilisation en routine du test Oncotype DX® dans la prise en charge des cancers du sein en Franche-Comté. Bulletin du Cancer. 101(7-8). 681–689. 6 indexed citations

16.

Curtit, Elsa, Virginie Nerich, Laura Mansi, et al.. (2013). Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis. The Oncologist. 18(6). 667–674. 73 indexed citations

17.

Nerich, Virginie, Bruno Lioure, Christian Récher, et al.. (2011). Induction-related cost of patients with acute myeloid leukaemia in France. International Journal of Clinical Pharmacy. 33(2). 191–199. 17 indexed citations

18.

Fagnoni, Philippe, Nöel Milpied, Samuel Limat, et al.. (2009). Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

19.

Nerich, Virginie, Élisabeth Monnet, Alain Weill, et al.. (2009). Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables. Inflammatory Bowel Diseases. 16(5). 813–821. 39 indexed citations

20.

Nerich, Virginie, Edgar Tissot, A. Faradji, et al.. (2007). Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres. Pharmacy World & Science. 30(3). 287–292. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact